December 13, 2019
Rose
In August, the maker of the treatment, Sarepta, said the FDA rejected the drug over the risk of infections seen in animal experiments. The new approval announcement made no mention of the prior rejection.
from Kaiser Health News https://ift.tt/2EqDzil
December 13, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Virginia House Passes Gun Control Bills Including Background Checks, ‘Red Flag’ Ban- Why Home Health Care Is Suddenly Harder To Come By For Medicare Patients
- As VA Tests Keto Diet To Help Diabetic Patients, Skeptics Raise Red Flags
- First Edition: February 3, 2020
- State Highlights: Colorado Hospitals Withdraw Reinsurance Lawsuit Making Budget Deal More Likely; Governor’s Panel Recommends Reforms For Alabama’s Troubled Prisons
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment